# US 2016/0256576 A1 · Composition, method, system and kit for optical electrophysiology

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0256576 A1
- Document ID: US20160256576A1
- Status: Published application
- Kind: A1
- Application number: 15/159,376
- Filed: 2016-05-19
- Published: 2016-09-08
- Earliest claimed: 2006-10-24
- Assignees: The Research Foundation of State University of New York; University of Connecticut
- Applicants: The Research Foundation of State University of New York; The University of Connecticut
- Inventors: Arkady M. Pertsov; Arvydas Matiukas; Leslie M. Loew; Joseph P. Wuskell
- Web page: https://patentgrep.com/patent/US20160256576A1

## CPC

- A61K 49/0032: {Methine dyes, e.g. cyanine dyes}
- A61B 5/0059: {using light, e.g. diagnosis by transillumination, diascopy, fluorescence (photoacoustic A61B5/0093; optical measurement of heart rate A61B5/02416; optical measurement of blood flow A61B5/0261; optical measurement of analytes A61B5/1455)}
- A61B 5/0071: {by measuring fluorescence emission}
- A61B 5/24: Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61K 49/006: {Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery}
- C09B 23/0075: {the polymethine chain being part of an heterocyclic ring}
- C09B 23/107: {four >CH- groups}
- G01N 21/4795: {spatially resolved investigating of object in scattering medium (in vivo A61B)}
- G01N 21/6428: {Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" (in vivo A61B5/00; immunoassay G01N33/53)}
- A61B 2503/40: Animals
- A61K 49/0017: {Fluorescence in vivo}
- A61K 49/0019: {characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- C09B: ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES {, e.g. PIGMENTS}; MORDANTS; LAKES (fermentation or enzyme using processes to synthesise a desired chemical compound C12P)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention provides a method of optical electrophysiological probing, including: providing a fluorescing chemical probe; contacting a thick portion of tissue with the fluorescing chemical probe to create a thick portion of treated tissue; applying a first range of wavelengths of electromagnetic radiation to the treated portion of tissue; and detecting a plurality of depth-specific emission wavelengths emitted from the thick portion of treated tissue.

## Claims

### Claim 1

An optically mapping composition comprising a voltage-sensitive dye of the formula:
wherein R1 is a first hydrocarbon group that is a butyl group;
R2 is a second hydrocarbon group that is a butyl group;
and R3 is a trimethylpropyl ammonium polar group.

### Claim 2 (depends on 1)

The composition of claim 1, having the formula:

### Claim 3 (depends on 1)

The composition of claim 1, further comprising a delivery agent that is at least one of a physiologically acceptable adjuvant, solvent, substrate, or diluent.

### Claim 4 (depends on 3)

The composition of claim 3, wherein the delivery agent is selected from the group consisting of: Pluronic F-127, Pluronic L64, cyclodextrin, gamma cyclodextrin, dimethylsulfoxide, ethanol, and combinations thereof.
